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In the past decade there have seen extensive changes in the services 
available to drug users in Ireland with the expansion in the Drug 
Treatment Services in response to the Government Strategy to 
Prevent Drug Misuse 1991 and The National AIDS Strategy 
Commission report 1992. In 1998 the Health Services introduced 
the methadone protocol, one of the most stringent in Europe, to 
control the prescribing and dispensing of methadone. 
 At present it is estimated that there are over 13,000 heroin 
addicts in Dublin. The National Advisory Committee on Drugs 
Prevalence Survey for 2002/2003 report lifetime prevalence rates 
for all adults in the Republic of Ireland for the use of heroin as 
0.5%, cocaine as 3.1%, other opiates as 3.1%, and any illegal 
substance as 19%. 
 Currently there are approximately 7,000 individuals in Ireland 
receiving methadone treatment. There are over 55 methadone 
treatment clinics in the Eastern region, and almost one third of 
individuals are placed with community GPs. There has also been a 
significant expansion in the availability of needle exchange 
programmes and at present there are approximately 14 programmes 
serving the Dublin area. Patients attending these services have 
access to methadone, clean injecting equipment, counselling, sex 
education and contraceptive advice, and all have free access to 
condoms. The implementation of these various harm reduction 
strategies was primarily a public health response to reduce the 
spread of HIV and other infectious viruses, to improve health, 
lifestyle, and to reduce criminal activity associated with illegal drug 
use. 
 The National Disease Surveillance Centre (NDSC) in Dublin 
publishes annual reports on the incidence and prevalence of 
infectious diseases, including HIV sexually transmitted diseases and 
infectious hepatitis. Injecting drug users represent approximately 
40% of the total cohort of HIV infected individuals in Ireland. The 
cumulative total of HIV infections in Ireland to the end of 
December 2002 was 3009. During 2002 there were 364 newly 
diagnosed cases of HIV infection, an increase of 22% of cases 
diagnosed in 2001.2 It was also reported that the total number of 
modifiable sexually transmitted diseases, of which there are 
currently 14, 
increased by 9.4% in 2002 compared with those in 2001. 
 The numbers of infectious hepatitis B notifications continued 
to increase in 2002 with 458 cases being notified, the number of 
viral hepatitis type unspecified, were similar in 2002 to 2001, and 
most of these were due to hepatitis C. Interestingly hepatitis C was 
not a notifiable disease, however recent public health initiatives 
have been put in place and from 2004 hepatitis C will become 
notifiable. 
 Whilst HIV infection is primarily a sexually transmitted 
disease, its main mode of transmission among intravenous drug 
users is through the sharing of contaminated injecting equipment. 
Much evidence has become available over the past decade to 
confirm that drug injectors have reduced their sharing of equipment 
in response to a wide variety of prevention programmes including 
methadone treatment services and needle exchange programmes.3,4 
These programmes have been shown to reduce the transmission of 
infectious viruses, to reduce the incidence of many medical 
complications associated with the injecting of substances such as 
deep vein thrombosis, abscesses, septicaemia etc, as well as 
improving the overall general health and well-being of substance 
misusers. 
Saving the tax payer 
Whilst they offer an opportunity to encourage risk reduction and to 
provide counselling and access to healthcare for all individuals at 
high risk, they have also been shown to be cost effective. The 
British NTORS study found that for every £1 spent on treatment 
there is a return of more than £3 in terms of savings associated with 
victim costs due to crime. Methadone treatments not only reduce 
demands upon the criminal justice system, but have also been found 
to have significant benefits in terms of health savings, therefore 
benefiting society in general, 
High risk sexual behaviour 
However, changing sexual risk behaviour has proved to be 
considerably more difficult. The relationship between sexual 
behaviour and drug use is complex. Levels of reported condom use 





comparable to that of the heterosexual population as a whole with 
approximately 70% never using condoms with primary partners, 
and 50% never using condoms with casual partners. A study carried 
out in Dublin in 1997 by the Drug Treatment Centre Board, 
measured the prevalence of HIV and risk behaviours in 185 Irish 
intravenous drug users, and concluded that sexual risk behaviour 
was high, with 50% of males and 63% of females never using 
condoms with regular sexual partners. 
 Female intravenous drug users were found to be at greater risk 
of HIV infection that their male counterparts and they concluded 
that there was a high potential for sexual spread of HIV into the 
non-injecting heterosexual population.5 The NDSC reports that the 
majority of newly diagnosed cases of HIV in 2003 were amongst 
heterosexuals (63.5%), that the number of cases of transmission 
among heterosexuals increased by 34% between 2001 and 2002. 
The rates of sexually transmitted diseases are increasing not only in 
injecting drug users, but also in the population as a whole, therefore 
it seems more work is needed to promote safer sexual practices, not 
only among intravenous drug users but the population in general.2 
 In light of this, further prevention efforts should therefore be 
focused not only on people who misuse substances themselves but 
on their partners, those who exchange sex to support an addiction 
and people who have multiple social, financial and educational 
problems. It would appear that cities with the most success in 
averting HTV epidemics have intervention developments that 
emphasise rapid reorientation towards user-friendly and low 
threshold services, community based approaches and public policies 
supportive of such interventions. Practical interventions include 
outreach, peer and social interventions, sex education, as well as 
legal access to sterile injecting equipment and low threshold agonist 
pharmacology in the form of methadone treatment programmes, 
Indeed, a study conducted in Glasgow in 1996 reported that if 
multidisciplinary health and social care are provided to street sex 
workers at a time and place that are convenient to their work, then 
the benefits are considerable and in their study they report 
prevalence rates of HIV infection amongst women remaining less 
than 5%.6 
 Whilst the importance of preventing the sharing of injecting 
equipment is well established, and considerable data is available to 
show that needle exchange programmes and methadone treatment 
programmes are effective in reducing the spread of infectious 
viruses, they also offer an opportunity for those already diagnosed 
with such illnesses to engage in and receive treatment.7,8 Patients 
attending these services are routinely offered virology screening, 
and where appropriate are offered vaccination. Data exists to show 
that those already infected with HIV have a greater rate of uptake of 
receiving highly active antiretroviral therapy and adherence to 
treatment if attending a methadone programme.9 
 There is little doubt of the value to drug users and to society in 
general that these services provide both in terms 
of general health and social well being, as well as the money saved 
in terms of the criminal justice system and Health Services. 
Declines in HIV and AIDS incidence in intravenous drug users are 
indirectly attributable to these services. The increase in HIV 
antibody positive cases among heterosexuals may reflect a relapse 
in safe sex behaviour, and we should not only target the substance 
misusing population but target education programmes aimed at 
individuals who work closely with young people such as youth 
workers, teachers, probation officers and juvenile liaison officers, 
for the benefit of society as a whole. 
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